SciDev.Net

A truth commission can account for South Africa's past HIV/AIDS denialist policies and rebuild trust, says AIDS expert, Salim S. Abdool Karim.

A UNITAID patent pool could revolutionise HIV treatment and research in developing countries — if payment can be agreed, says Priya Shetty.

More research is needed on how to tackle HIV with antiretroviral therapy, say Kevin M De Cock and colleagues at the WHO.

New and existing HIV/AIDS treatments provide hope that the disease can be eliminated, says an editorial in New Scientist.

Mobile phones can improve health services and provide help for displaced patients during political crises, say Richard Lester and Sarah Karanja.

Other countries could learn from Vietnam's progress on communicating science and risk, says Son Kim Phan.

China's improved accessibility to HIV/AIDS statistics is a good start to the disease's control in the country, says an editorial in Nature.

The UN programme for HIV/AIDS is out of touch with reality and hindering health capacity building, argues Roger England.

Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.

Revised HIV/AIDS figures are a sign of better data, not that the epidemic is slowing. There is still much to be done, says Kevin De Cock.

Twenty-five years after the discovery of HIV, there is no marketable AIDS vaccine — and it is uncertain whether there ever will be, writes Robert Steinbrook.

AIDS denial beliefs are spreading on the Internet and scientists must fight this together, say Tara C. Smith and Steven P. Novella.

Science needs to be injected into the controversy over use of nutritional supplements in tackling HIV and tuberculosis, says Wieland Gevers.

Clinicians should learn from the alarmist media coverage that followed a recent microbicide trial, say Gita Ramjee and colleagues.

Now that they have been freed, Libya should admit the innocence of medics involved in the HIV infection case, says a Nature editorial.

Despite the political difficulties, field trials of AIDS prevention methods must be continued, argues this Nature editorial.

Developing nations must pay more than mere lip service to WHO advice on linking HIV/AIDS and tuberculosis programmes, says Peter Mugyenyi.

Thailand is right to take action when companies do not make essential drugs available and affordable, argue Paul Cawthorne and colleagues.

South Africa's long-awaited strategy to tackle AIDS is sound, but may face technical and bureaucratic obstacles, says a Nature editorial.

All countries need to take responsibility for fighting tuberculosis if the disease is to be eradicated, says an editorial in The Lancet.